Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart socks for seniors? High-Tech insole aims to keep frail elderly on their feet

NCT ID NCT02316600

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smart shoe insole that tracks movement and encourages walking in frail older adults living at home. About 70 people aged 65 and older took part to see if they would accept and use the device in daily life. The goal was to learn how well the insole works for monitoring frailty and motivating activity, not to treat or cure any condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Start date

Jan 2015

Finished

Jul 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged 65 or more, living at home; * Presenting a frailty syndrome for the second phase, and robust volunteers for the first phase; * Informed and written consent by the patient or the legal representative or the reliable person when appropriate. Exclusion Criteria: * No access to ADSL; * Patient's life expectancy less than 12 months; * Patient presenting disability with an Activity of Daily Living score \< 4/6 and/or a Mini Mental State \<24/30; * Non agreement of study participation of patients or legal representative or the reliable person when appropriate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fragility are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital, Toulouse

    Toulouse, Midi-Pyrenes, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.